Cardiac complication after experimental human malaria infection: A case report

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Nieman, An Emmie ^a   De Mast, Quirijn ^a   Roestenberg, Meta ^a   Wiersma, Jorien ^a   Pop, Gheorghe ^a   Stalenhoef, Anton ^a   Druilhe, Pierre ^b   Sauerwein, Robert ^a   Van Der Ven, André ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ARTEMETHER PLUS BENFLUMETOL; ASPARTATE AMINOTRANSFERASE; CARBASALATE CALCIUM; CLOPIDOGREL; CORTICOSTEROID; CREATINE KINASE; ENOXAPARIN; GLUCOSE; GLYCERYL TRINITRATE; LACTATE DEHYDROGENASE; LIPID; LSA 3 RECOMBINANT PROTEIN; MALARIA VACCINE; METOPROLOL; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PERINDOPRIL; TROPONIN I; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADJUVANT THERAPY; ADULT; ANGINA PECTORIS; ARTICLE; ATOPY; BED REST; BLOOD SMEAR; CASE REPORT; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE; FATIGUE; FEMALE; FOLLOW UP; HAY FEVER; HEADACHE; HEART FUNCTION; HOSPITAL DISCHARGE; HUMAN; HYPOKINESIA; IMMUNIZATION; INJECTION SITE PAIN; LABORATORY TEST; MALARIA FALCIPARUM; MOSQUITO; MYALGIA; MYOCARDITIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; PLASMODIUM FALCIPARUM; PROGNOSIS; RETROSTERNAL PAIN; ST SEGMENT ELEVATION; T WAVE; THORAX PAIN; VACCINATION; ANIMAL; DRUG COMBINATION; HUMAN EXPERIMENT; IMMUNOLOGY; INSECT BITE; ISOLATION AND PURIFICATION; PARASITEMIA; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMAN EXPERIMENTATION; HUMANS; INSECT BITES AND STINGS; MALARIA VACCINES; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; VACCINATION;

EID: 73649093770     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-277     Document Type: Article

References (53)

1. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. JE Epstein S Rao F Williams D Freilich T Luke M Sedegah P de la Vega J Sacci TL Richie SL Hoffman, J Infect Dis 2007 196 145 154 10.1086/518510 17538895
2. Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. DF Verhage DS Telgt JT Bousema CC Hermsen GJ van Gemert JW van der Meer RW Sauerwein, Neth J Med 2005 63 52 58 15768480
3. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. LW Church TP Le JP Bryan DM Gordon R Edelman L Fries JR Davis DA Herrington DF Clyde MJ Shmuklarsky I Schneider TW McGovern JD Chulay WR Ballou SL Hoffman, J Infect Dis 1997 175 915 920 10.1086/513990 9086149
4. Pre-erythrocytic malaria vaccines: towards greater efficacy. AV Hill, Nat Rev Immunol 2006 6 21 32 10.1038/nri1746 16493425
5. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. DF Clyde, Am J Trop Med Hyg 1975 24 397 401 808142
6. Electrocardiographic monitoring in severe falciparum malaria. DB Bethell PT Phuong CX Phuong F Nosten D Waller TM Davis NP Day J Crawley D Brewster S Pukrittayakamee NJ White, Trans R Soc Trop Med Hyg 1996 90 266 269 10.1016/S0035-9203(96)90241-2 8758072
7. Cardiac involvement during and after malaria. D Franzen JM Curtius W Heitz HW Hopp V Diehl HH Hilger, Clin Investig 1992 70 670 673 10.1007/BF00180283 1392443
8. The effects of malaria on the heart. HB Sprague, Am Heart J 1946 31 426 430 10.1016/0002-8703(46)90424-3
9. Analysis of malaria cases among United Nations troops in Sierra Leone. GI Kawar JF Maayah BT Rawashdeh, Saudi Med J 2003 24 881 884 12939677
10. Circulating concentrations of cardiac proteins in complicated and uncomplicated Plasmodium falciparum malaria. S Ehrhardt D Wichmann CJ Hemmer GD Burchard NW Brattig, Trop Med Int Health 2004 9 1099 1103 10.1111/j.1365-3156. 2004.01303.x 15482402
11. Myocardial damage in falciparum malaria detectable by cardiac troponin T is rare. A Gunther MP Grobusch H Slevogt W Abel GD Burchard, Trop Med Int Health 2004 8 30 32 10.1046/j.1365-3156.2003.00978.x
12. Fatal complications of tropical malaria in non-immune patients. A retrospective clinico-pathologic analysis of 25 cases. RD Horstmann JH Ehrich J Beck M Dietrich, Dtsch Med Wochenschr 1985 110 1651 1656 10.1055/s-2008-1069063 3899570
13. Myocarditis associated with Plasmodium falciparum malaria: a case report and a review of the literature. AH Mohsen ST Green JN West MW McKendrick, J Travel Med 2001 8 219 220 11712506
14. Severe malaria - analysis of prognostic symptoms and signs in 169 patients treated in Gdynia in 1991-2005. J Goljan WL Nahorski A Wroczynska I Felczak-Korzybska H Pietkiewicz, Int Marit Health 2006 57 149 162 17312703
15. Fatal malaria in a German couple returning from Burkina Faso. O Wichmann T Loscher T Jelinek, Infection 2003 31 260 262 14562954
16. Cardiotoxicity of antimalarial drugs. NJ White, Lancet Infect Dis 2007 7 549 558 10.1016/S1473-3099(07)70187-1 17646028
17. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. C Hatz J Soto HD Nothdurft T Zoller T Weitzel L Loutan F Bricaire F Gay GD Burchard K Andriano G Lefevre PI De Palacios B Genton, Am J Trop Med Hyg 2008 78 241 247 18256423
18. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefevre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop Med Hyg 2001 64 247 256 11463111
19. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. R McGready K Stepniewska N Lindegardh EA Ashley Y La P Singhasivanon NJ White F Nosten, Eur J Clin Pharmacol 2006 62 1021 1031 10.1007/s00228-006-0199-7 17053895
20. Coronary artery vasospasm in 17 y/o after Riamet. 2004 http://www.novartis.com Novartis database. Ref Type: Report
21. Personal communication by T. Richie, SL Hoffman (Naval Medical Research Centre (NMRC) and Walter Reed Army Institute of Research (WRAIR), USA) and A. Hill (Centre for Clinical Vaccinology and Tropical Medicine in Oxford, UK). 2008 Ref Type: Personal Communication
22. DPS. Risk and side effects associated with estrogen-progestin contraceptives - UpToDate. KA Martin, 2008 Ref Type Report
23. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group, Hum Reprod Update 2006 12 483 497 10.1093/humupd/dml028 16807276
24. Birth anomalies of coronary arteries. Responsibility in myocardial ischemia. JA Salloum D Thomas Y Grosgogeat, Presse Med 1992 21 1172 1174 1409467
25. Angina with "normal" coronary arteries: a changing philosophy. R Bugiardini CN Bairey Merz, JAMA 2005 293 477 484 10.1001/jama.293.4.477 15671433
26. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). FH Zimmerman A Cameron LD Fisher G Ng, J Am Coll Cardiol 1995 26 654 661 10.1016/0735-1097(95)00254-2 7642855
27. Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. I Kardasz R De Caterina, J Intern Med 2007 261 330 348 10.1111/j.1365-2796.2007.01788.x 17391108
28. Cigarette smoking is a major risk factor for coronary spasm. M Sugiishi F Takatsu, Circulation 1993 87 76 79 8419026
29. Prinzmetal's angina. KB Keller L Lemberg, Am J Crit Care 2004 13 350 354 15293589
30. Cardiovascular complications of cocaine use. RA Lange LD Hillis, N Engl J Med 2001 345 351 358 10.1056/NEJM200108023450507 11484693
31. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. AA El Menyar, J Postgrad Med 2006 52 51 56 16534169
32. Tissue factor in infection and severe inflammation. M Levi T van der Poll H ten Cate, Semin Thromb Hemost 2006 32 33 39 10.1055/s-2006-933338 16479460
33. Endothelial dysfunction in childhood infection. M Charakida AE Donald M Terese S Leary JP Halcox A Ness SG Davey J Golding P Friberg NJ Klein JE Deanfield, Circulation 2005 111 1660 1665 10.1161/01.CIR.0000160365.18879.1C 15795332
34. Endothelial function and coronary spastic angina. H Kawano H Ogawa, Intern Med 2005 44 91 99 10.2169/internalmedicine.44.91 15750267
35. The role of von Willebrand factor in thrombus formation 2. ZM Ruggeri, Thromb Res 2007 120 Suppl 1 5 S9 10.1016/j.thromres.2007.03.011 17493665
36. Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. Q de Mast E Groot PJ Lenting PG de Groot M McCall RW Sauerwein R Fijnheer A van de Ven, J Infect Dis 2007 196 622 628 10.1086/519844 17624850
37. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. AO Spiel JC Gilbert B Jilma, Circulation 2008 117 1449 1459 10.1161/CIRCULATIONAHA.107.722827 18347221
38. von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. MJ Hollestelle C Donkor EA Mantey SJ Chakravorty A Craig AO Akoto J O'Donnell JA van Mourik J Bunn, Br J Haematol 2006 133 562 569 10.1111/j.1365-2141.2006.06067.x 16681646
39. Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. P Ammann S Marschall M Kraus L Schmid W Angehrn R Krapf H Rickli, Chest 2000 117 333 338 10.1378/chest.117.2.333 10669671
40. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. N Lakkis H Dokainish M Abuzahra V Tsyboulev J Jorgensen AP De Leon A Saleem, J Am Coll Cardiol 2004 44 2091 2093 10.1016/j.jacc.2004.05.033 15542299
41. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease 1. G Endler A Klimesch H Sunder-Plassmann M Schillinger M Exner C Mannhalter N Jordanova G Christ R Thalhammer K Huber R Sunder-Plassmann, Br J Haematol 2002 117 399 404 10.1046/j.1365-2141.2002.03441.x 11972524
42. Histamine-induced coronary artery spasm: the concept of allergic angina. NG Kounis GM Zavras, Br J Clin Pract 1991 45 121 128 1793697
43. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? NG Kounis, Int J Cardiol 2006 110 7 14 10.1016/j.ijcard.2005. 08.007 16249041
44. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. L Sarda P Colin F Boccara D Daou R Lebtahi M Faraggi C Nguyen A Cohen MS Slama PG Steg D Le Guludec, J Am Coll Cardiol 2001 37 786 792 10.1016/S0735-1097(00)01201-8 11693753
45. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. PD Sorlie FJ Nieto E Adam AR Folsom E Shahar M Massing, Arch Intern Med 2000 160 2027 2032 10.1001/archinte.160.13.2027 10888976 (Pubitemid 30437586)
46. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. P Patel MA Mendall D Carrington DP Strachan E Leatham N Molineaux J Levy C Blakeston CA Seymour AJ Camm, BMJ 1995 311 711 714 7549683
47. Coxsackie B virus and myocardial infarction. HD Foster, Lancet 2002 359 804 10.1016/S0140-6736(02)07871-6 11888636
48. Infection and infarction. Acute viral (and other) infection in the onset, pathogenesis, and mimicry of acute myocardial infarction. DH Spodick, Am J Med 1986 81 661 668 10.1016/0002-9343(86)90554-1 3532790
49. Risk of myocardial infarction and stroke after acute infection or vaccination. L Smeeth SL Thomas AJ Hall R Hubbard P Farrington P Vallance, N Engl J Med 2004 351 2611 2618 10.1056/NEJMoa041747 15602021
50. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. RE Eckart SS Love JE Atwood MK Arness DC Cassimatis CL Campbell SY Boyd JG Murphy DL Swerdlow LC Collins JR Riddle DN Tornberg JD Grabenstein RJ Engler, J Am Coll Cardiol 2004 44 201 205 10.1016/j.jacc.2004.05. 004 15234435
51. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. F Boccara N Haiem-Sigaux A Cohen, Chest 2001 120 671 672 10.1378/chest.120.2.671 11502677
52. Recurrent reversible dilated cardiomyopathy secondary to viral and streptococcal pneumonia vaccine-associated myocarditis. AN Makaryus DJ Revere B Steinberg, Cardiol Rev 2006 14 1 e4 10.1097/01.crd.0000174803.68564.65 16788323
53. Comparison of clinical presentation of acute myocarditis following smallpox vaccination to acute coronary syndromes in patients <40 years of age. RE Eckart EA Shry SO Jones JE Atwood JD Grabenstein, Am J Cardiol 2005 95 252 1255 10.1016/j.amjcard.2005.01.061 (Pubitemid 40616436)